TELIX PHARMACEUTICALS LIMITED (TLX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

TLX - TELIX PHARMACEUTICALS LIMITED

Year End: December
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.07

20 Mar
2023

-0.160

OPEN

$7.23

-2.21%

HIGH

$7.34

1,046,635

LOW

$7.03

OTHER COMPANIES IN THE SAME SECTOR
CUV . ACR . AHZ . CSL . IDT . IVX . MSB . MYX . RNO . OSL . TFC . TIS . KZA . AGH . FTT . PAR . ADO . PYC . RAC . RCE . ZNO . OCC . ACW . AVH . LGP . SPL . ARX . AFP . 1AD . PNV . MVP . BNO . NXS . GSS . EOF . NEU . PAL . PBP . BOT . IMU . MDC . IMM . PXS . HXL . MXC . MAP . CAU . OPT . ANP . TRP . BIO .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 20182019202020212022
EPS Basic xxxxxxxxxxxx-33.5
DPS All xxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxx160.1 M
Book Value Per Share xxxxxxxxxxxx25.3
Net Operating Cash Flow xxxxxxxxxxxx-64.0 M
Net Profit Margin xxxxxxxxxxxx-65.01 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20182019202020212022
Return on Capital Employed xxxxxxxxxxxx-253.34 %
Return on Invested Capital xxxxxxxxxxxx-221.73 %
Return on Assets xxxxxxxxxxxx-56.20 %
Return on Equity xxxxxxxxxxxx-253.34 %
Return on Total Capital xxxxxxxxxxxx-153.82 %
Free Cash Flow ex dividends xxxxxxxxxxxx-71.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

TLX STOCK CHART